Technology

The prospective, multicenter study enrolled 318 patients across 20 US sites.

The expansion follows a 30% year-over-year growth rate.

The conference runs from March 11-14 in Orlando, Florida.

The clinical study will evaluate a noninvasive corneal strengthening procedure designed to reshape the cornea and correct refractive errors in-office without tissue removal.

According to a VSP Vision Care news release, 71% say they experience performance impacts due to screen-related visual discomfort, equating to nearly one full workday of lost productivity each week.

Vision rehabilitation includes training patients in the use of adaptive technologies, such as magnifiers or screen readers, and nonvisual techniques to facilitate the patients’ ability to complete daily tasks.

Jade Coats, OD, FAAO, and Cecelia Koetting, OD, FAAO, DipABO, provide a sneak peek into their 2-day session at the conference.

This research is part of the IIH Research and Treatment Initiative, a new philanthropy-funded program launched at Mass General Brigham.

Two recent journal articles underscore the organ’s importance in identifying systemic disease processes.

ODs are gearing up for anticipated advancements in specialty lens and lenses for myopia management and patients with astigmatism.

Employers are obliged to provide employees with appropriate safety eyewear and face protection that conforms to the industry standard.

Evolutions in AI, myopia management, and individualized care are on ODs' minds for the new year.

VR technology captures not only visual fields but a full “stack” of pretest results.

Maturing of the vestibulo-ocular reflex is independent of sensory input.

The cross-linking system does not disrupt the epithelium, and does not require documentation of disease progression, according to a press release from Epion Therapeutics.

The latest in drug and technology developments and updates from September 2025.

The country aims to ensure that more than 95% of patients with diabetes receive timely retinal examinations.

The research, published in JAMA Health Forum, examined 950 AIMDs approved by the US Food and Drug Administration as of November 2024.

The latest in drug and technology developments and updates from August 2025.

Optometry's Meeting hosted an array of eye care professionals in Minneapolis, Minnesota, from June 25 to 28, 2025.

Data used in the post hoc analysis were from 56 parameters from 4 testing modalities obtained in a multicenter US trial (NCT03197870).

In a climate of shrinking reimbursements and rising costs, finding your niche isn’t just smart—it’s essential.

The latest in drug and technology developments and updates from July 2025.

The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.

This will be the Flying Eye Hospital’s first visit to Rwanda.